Amoxicillin; Vonoprazan Fumarate Patent Expiration
Amoxicillin; Vonoprazan Fumarate was first introduced by Phathom Pharmaceuticals Inc
Amoxicillin; Vonoprazan Fumarate Patents
Given below is the list of patents protecting Amoxicillin; Vonoprazan Fumarate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Voquezna Dual Pak | US9186411 | Pharmaceutical composition | Aug 11, 2030 | Phathom |
| Voquezna Dual Pak | US7977488 | 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors | Aug 11, 2028 | Phathom |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Amoxicillin; Vonoprazan Fumarate's patents.
Latest Legal Activities on Amoxicillin; Vonoprazan Fumarate's Patents
Given below is the list recent legal activities going on the following patents of Amoxicillin; Vonoprazan Fumarate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Second letter to regulating agency to determine regulatory review period | 01 Mar, 2024 | US7977488 |
| Letter from FDA or Dept of Agriculture re PTE application | 24 Jan, 2024 | US7977488 |
| Initial letter Re: PTE Application to regulating agency | 17 Aug, 2023 | US7977488 |
| Change in Power of Attorney (May Include Associate POA) Critical | 16 Jun, 2023 | US9186411 |
| Email Notification Critical | 16 Jun, 2023 | US9186411 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 20 Apr, 2023 | US9186411 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 20 Dec, 2022 | US7977488 |
| Change in Power of Attorney (May Include Associate POA) Critical | 13 Jul, 2022 | US7977488 |
| Email Notification Critical | 13 Jul, 2022 | US7977488 |
| Correspondence Address Change Critical | 12 Jul, 2022 | US7977488 |
Amoxicillin; Vonoprazan Fumarate's Family Patents
